One of the “trickiest parts” about children receiving gender-affirming hormone therapy is the likelihood that they will be infertile, according to Dr. Kathryn Lowe, a fellow with the American Academy of Pediatrics (AAP).
The remark was made at an annual meeting of the Wisconsin AAP in May and recirculated online on Dec. 6.